Strategic Collaboration Maastro collaborates with Maastricht University Medical Centre and the GROW Research School to optimize cancer treatment through education and scientific research, presenting a potential for partnerships in clinical trials, data sharing, and joint innovation programs.

Clinical Excellence As a TZO recognized top clinical institution specializing in radiotherapy, Maastro represents a premium partner for advanced radiotherapy solutions, training, and standardized care programs that can drive adoption and validation of new technologies.

Growth Readiness With 201-500 employees and ongoing clinical research activity, Maastro may be receptive to scale-up in radiotherapy technology, software platforms, or analytics services that support throughput, outcomes tracking, and research capabilities.

Technology Fit Current tech stack includes analytics and web optimization tools (Matomo, Cloudflare), integration platforms (iCIMS), and UI frameworks (Tailwind CSS), indicating openness to data-driven solutions, secure web services, and user-friendly clinical IT enhancements.

Market Alignment Operating in hospitals and health care with similar peers of mid-to-large cancer centers, Maastro sits in a market segment that values proven radiotherapy innovations, clinical research collaboration, and outcomes-based procurement.